THE RATIONALE FOR PLATELET-RICH PLASMA (PRP) THERAPY IN CHRONIC WOUNDS: SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/y14j0w95Keywords:
Chronic wounds, Platelet, Platelet rich plasmaAbstract
Introduction: Chronic wounds are common and reduce quality of life. The financial burden of dressing materials, amputation costs, and the ongoing and extended need for human resources to treat wounds affects healthcare resource utilization. Platelet-rich plasma (PRP) has been shown to increase the healing rates of open diabetic foot ulcers and venous ulcers.
The aim: This article demonstrated the rationale for platelet-rich plasma (PRP) therapy in chronic wounds.
Methods: This study demonstrated that it met all of the requirements by comparing itself to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 guidelines. As a result, the specialists were able to ensure that the study was as up to date as possible. Publications published between 2013 and 2023 were considered for this search strategy. This was accomplished using a variety of online reference sources, including Pubmed and SagePub. It was chosen not to include review pieces, previously published works, or works that were just partially completed.
Result: In the PubMed database, the results of our search brought up 76 articles and SagePub 62 articles. The results of the search conducted for the last year of 2013 yielded a total 16 articles for PubMed and 12 articles from SagePub. In the end, we compiled a total of six papers.
Conclusion: PRP is composed of several components obtained from platelets, including growth factors and cytokines. These bioactive substances have a significant role in modulating processes such as inflammation, angiogenesis, stem cell activity, and cellular proliferation.
References
Caruana A, Savina D, Macedo JP, Soares SC. From platelet-rich plasma to advanced platelet-rich fibrin: biological achievements and clinical advances in modern surgery. Eur J Dent. 2019;13(02):280–6.
Sanchez M, Garate A, Bilbao AM, Oraa J, Yanguela F, Sanchez P, et al. Platelet-Rich Plasma for Injured Peripheral Nerves: Biological Repair Process and Clinical Application Guidelines. Intech Open. 2018;1–9.
Alves R, Grimalt R. A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification. Ski Appendage Disord. 2018;4:18–24.
Zhang W, Guo Y, Kuss M, Shi W, Aldrich AL, Untrauer J, et al. Platelet-rich plasma for the treatment of tissue infection: preparation and clinical evaluation. Tissue Eng Part B Rev. 2019;25(3):225–36.
Le ADK, Enweze L, DeBaun MR, Dragoo JL. Current clinical recommendations for use of platelet-rich plasma. Curr Rev Musculoskelet Med. 2018;11:624–34.
Chicharro-Alcántara D, Rubio-Zaragoza M, Damiá-Giménez E, Carrillo-Poveda JM, Cuervo-Serrato B, PeláezGorrea P, et al. Platelet rich plasma: new insights for cutaneous wound healing management. J Funct Biomater. 2018;9(1):10.
Verma R, Kumar S, Garg P, Verma YK. Platelet-rich plasma: A comparative and economical therapy for wound healing and tissue regeneration. Cell Tissue Bank. 2023;24(2):285–306.
Collins T, Alexander D, Barkatali B. Platelet-rich plasma: a narrative review. EFORT open Rev. 2021;6(4):225–35.
Kapp S, Miller C, Santamaria N. The quality of life of people who have chronic wounds and who self‐treat. J Clin
Nurs. 2018;27(1–2):182–92.
Olsson M, Järbrink K, Divakar U, Bajpai R, Upton Z, Schmidtchen A, et al. The humanistic and economic burden of chronic wounds: A systematic review. Wound Repair Regen. 2019;27(1):114–25.
Lin L, Bi H, Wang X, Shi X. Impact of Platelet-Rich Fibrin Combined with Silver Nanoparticle Dressing on Healing Time and Therapeutic Efficacy of Chronic Refractory Wounds. Altern Ther Health Med. September 2023;29(6):264–7.
Helmy Y, Farouk N, Ali Dahy A, Abu-Elsoud A, Fouad Khattab R, Elshahat Mohammed S, et al. Objective assessment of Platelet-Rich Plasma (PRP) potentiality in the treatment of Chronic leg Ulcer: RCT on 80 patients with Venous ulcer. J Cosmet Dermatol. Oktober 2021;20(10):3257–63.
Pires BMFB, Baptista de Oliveira BGR, Bokehi LC, Luiz RR, Carvalho BTF, Santana RF, et al. Clinical and Microbiological Outcomes Associated With Use of Platelet-Rich Plasma in Chronic Venous Leg Uclers: A Randomized Controlled Trial. J wound, ostomy, Cont Nurs Off Publ Wound, Ostomy Cont Nurses Soc. 2021;48(4):292–9.
Tsai H-C, Lehman CW, Chen C-M. Use of platelet-rich plasma and platelet-derived patches to treat chronic wounds. J Wound Care. Januari 2019;28(1):15–21.
Liao X, Liang J-X, Li S-H, Huang S, Yan J-X, Xiao L-L, et al. Allogeneic Platelet-Rich Plasma Therapy as an Effective and Safe Adjuvant Method for Chronic Wounds. J Surg Res. Februari 2020;246:284–91.
Moneib HA, Youssef SS, Aly DG, Rizk MA, Abdelhakeem YI. Autologous platelet‐rich plasma versus conventional therapy for the treatment of chronic venous leg ulcers: a comparative study. J Cosmet Dermatol. 2018;17(3):495– 501.
Jones RE, Foster DS, Longaker MT. Management of chronic wounds—2018. Jama. 2018;320(14):1481–2.
Park JW, Hwang SR, Yoon IS. Advanced Growth Factor Delivery Systems in Wound Management and Skin Regeneration. Molecules. 2017;22(8):1–20.
He Z, Liu A, Yu J, Chen X. Role of platelet-rich plasma gel in promoting wound healing based on medical images of wounds. Contrast Media Mol Imaging. 2022;2022.
Bolton L. Platelet-Rich Plasma: Optimal Use in Surgical Wounds. Wounds a Compend Clin Res Pract. Agustus 2021;33(8):219–21.
Lee J, Jang H, Park S, Myung H, Kim K, Kim H, et al. Platelet-rich plasma activates AKT signaling to promote wound healing in a mouse model of radiation-induced skin injury. J Transl Med. 2019;17:1–10.
Xu P, Wu Y, Zhou L, Yang Z, Zhang X, Hu X, et al. Platelet-rich plasma accelerates skin wound healing by promoting re-epithelialization. Burn trauma. 2020;8:tkaa028.
Chung KC. Grabb and Smith’s Plastic Surgery: Eighth Edition. Philadelphia: Wolters Kluwer, 2020
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
